Cardio ID Flashcards

1
Q

Most common organisms for infective endocarditis

A
  • Most Common: staph aureus, viridians group strep (dental), coagulase negative staph, enterococci, strep bovis
  • IVDU: staph aureus, gram negative bacilli or polymicrobial infections
  • Prosthetic Valve: staph aureus, coagulase negative staph, enterococci or gram-negative bacilli
    ○ If patient grows enterococcus, may come from the gut and indicate colorectal cancer, requiring a colonoscopy
  • Native Valve:
    ○ Strep Viridians (sanguis, oralis, salivarius), enterococci, staphylococci
    ○ HACEK: fastidious gram negatives (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Treatment for infective endocarditis

A

IV benpen + fluclox + gen for 6 weeks unless

  • Native tricuspid valve S aureus without lung abscess - 2 weeks
  • Q fever, Whipples - months/years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications of surgical management

A
  • Cardiac failure or highly likely to develop
  • Abscess
  • Failing medical therapy - many days of bacteraemia
    • modifying factors (prosthetic valves, virulent organism, fit for surgery/re-do)

Absolute
• Severe aortic or mitral regurgitation
• Cardiac failure (related to valve dysfunction)
• Fungal or highly resistant organisms (VRE, MRSA)
• Perivalvular abscess or fistula
• Prosthetic valve endocarditis

Relative
• Multiple or severe embolism (on therapy)
• Uncontrolled infection (e.g., MSSA, Pseudomonas, Q fever)
• Size of vegetation (>1cm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Modified Duke Criteria

A

2 major or 1 major + 3 minor or 5 minor

MAJOR
MICRO
- Typical organisms x2 cultures: S aureus, S viridians, HACEK, enterococcus, S gallolyticus
- Other organism
- Coxiella burnetii serology/CPR/culture

ENDOCARDIAL (ECHO)

  • New valvular regurgitation
  • Abscess
  • Dehiscence of valve
  • Vegetation

MINOR

  • Fever > 38
  • Predisposition: prosthetic valve, IVDU
  • Vascular: emboli, mycotic aneurysm, Janeway
  • Immune: GN, RF, Osler, Roth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Endocarditis Prophylaxis

A

Antibiotic prophylaxis against infective endocarditis is recommended only for patients who meet both of the following criteria:

(1) Have a cardiac condition associated with an increased risk of developing infective endocarditis and the highest risk of adverse outcomes from endocarditis
(2) Undergoing a procedure associated with a high risk of a bacteraemia that is associated with endocarditis

(1) High risk cardiac condition
- Prosthetic cardiac valve
- Prosthetic material used for cardiac valve repair
- Previous IE
- Congenital heart disease but only if it involves
(a) Unrepaired cyanotic defects including palliative shunts
(b) repaired defects with residual defects at or adjacent to the site of a prosthetic patch
(c) repair < 6m ago with prosthetic
- Rheumatic heart disease and also ATSI/Maori/Pac Islander

(2) Procedures
- Dental procedures - extraction, periodontal surgery, reimplant tooth
- Tonsillectomy, adenoidectomy
- Infected skin
- Established UTI

Tx:

  • Amoxicillin 60 mins before
  • If hypersensitive to penicillin - cefalexin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute Rheumatic Fever

A
  • Acute systemic autoimmune disease secondary to streptococcal pharyngitis (group A β-haemolytic streptococcus - streptococcus pyogenes) → rheumatic carditis → rheumatic heart disease.
  • Usually occurs 2-3 weeks post-infection; tends to recur if untreated.
  • Skin (scabies/impetigo), pharyngitis

Group A strep-M protein and N-acetyl beta-D-glucosamine epitope cross-reactivity with myosin, laminin (heart) and basal ganglia plus immune complexes (joints)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Genetic predisposition for rheumatic fever

A

HLADR7
HLADQA1
HLADQB1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Jones criteria for rheumatic fever

A

Evidence of Group A B-haemolytic streptococcus (ASOT) and 2 MAJOR or 1 MAJOR + 2 MINOR

MAJOR (JONES)

  • Polyarthralgia
  • Carditis
  • Subcutaneous Nodules
  • Erythema marginatum
  • Sydenham chorea

MINOR (PEACE)

  • Previous rheumatic fever
  • ECG with prolonged PR interval
  • Arthralgias
  • CRP/ESR elevated
  • Elevated Temp Fever > 38
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which valve is normally affected in RHD?

A

Mitral

Aortic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Investigations for Group A B haemolytic strep

A
  • ASOT: for Group A Streptococcus bacteria (Streptococcus pyogenes).
  • ASO and anti-DNAse B are the most common antibodies produced by the body’s immune system in response to a Group A streptococcal infection
  • Associated with Aschoff bodies (granuloma with giant cells - blue arrows) which are inflamed areas in the myocardial tissue - they are areas of fibrinoid necrosis and contain immune cells and Anitschkow cells (enlarged macrophages with ovoid, wavy, rod like nucleus (like a caterpillar)) - red arrows), increased anti-streptolysin O (ASO) titres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment for acute rheumatic disease

A
  • Single dose IM benzathine benzylpenicillin to clear Group A strep
  • Arthralgia: high dose aspirin or naproxen
  • Chorea: anti-epileptics or anti dopamine agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of culture negative IE

A
  • IE with 3 –ve BC after 7 days
  • Previous antibiotics or cultures not taken
  • Inadequate lab or investigations

• Fastidious organism
Q fever, Bartonella, Streps, Legionella, Whipples,
Mycoplasma hominis, Chlamydophila, fungi, Brucella
• (Not HACEK now)
• Role of NAT incl. 16S PCR (or 18S PCR for fungi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Endocarditis prophylaxis

A
  • Current recommendations are ONLY for prosthetic valves, previous endocarditis, cyanotic congenital heart disease and some high risk lesions eg patent ductus
  • Post rheumatic fever exposure – daily penicillin for at least 10 years or until age 40, whichever is LONGEST.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Commonly affected valve in IE

A
  • IVDU: route of infection from skin to systemic veins → Right Atrium → Tricuspid Valve → right ventricle → pulmonary arteries (septic PE)
  • Otherwise mitral valve is most commonly affected
  • If aortic valve affected - it is very close to AV node and so ECG should be checked to look for heart block
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Which valve defect is most commonly associated with Infective Endocarditis?
Mitral stenosis
Mitral valve prolapse
Aortic stenosis
Tricuspid regurgitation
Aortic regurgitation
A

Mitral valve prolapse with regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment for rheumatic fever

A
  • Treatment for Group A Strep should be started within 9 days of the onset of symptoms to prevent rheumatic fever.
  • Aspirin is recommended as the first-line treatment for arthritis or arthralgia in ARF.
  • Sydenham chorea is self-limiting.
  • Most cases will resolve within weeks and almost all cases within 6 months, although rare cases may last as long as 2–3 years.
17
Q

Secondary prevention of recurrence for rheumatic fever treatment

A

Patients with acute rheumatic fever or rheumatic heart disease should receive antibiotic prophylaxis against Streptococcus pyogenes (group A streptococcus) infection to prevent recurrence of acute rheumatic fever and development or progression of rheumatic heart disease: IM Benzylpenicillin every 21 or 28 days
Can use erythromycin if allergic.

The duration of antibiotic prophylaxis depends on patient factors such as social circumstances, clinical features, and the likelihood of ongoing exposure to S. pyogenes and further episodes of acute rheumatic fever. The minimum duration is:

  • 10 years after the most recent episode of acute rheumatic fever, or until 21 years of age (whichever is longer) for patients without moderate or severe rheumatic heart disease
  • until 35 years of age for patients with moderate rheumatic heart disease
  • until 40 years of age or lifelong for patients with severe rheumatic heart disease and those who require or have had cardiac valve surgery for rheumatic heart disease.